Similar articles

• Clinical trials in adult AML.

  Stock W. Stock W. Clin Adv Hematol Oncol. 2009 Jun;7(6):8-10. Clin Adv Hematol Oncol. 2009. PMID: 19645130 Review. No abstract available.
• Molecular characteristics therapy in AML.

  Radich GP. Radich GP. Clin Adv Hematol Oncol. 2009 Jun;7(6):11-4. Clin Adv Hematol Oncol. 2009. PMID: 19645131 Review. No abstract available.
• Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.

  Suman VJ, Dueck A, Sargent DJ. Suman VJ, et al. Cancer Invest. 2008 Jun;26(5):439-44. doi: 10.1080/07357900801971057. Cancer Invest. 2008. PMID: 18568764 Review. No abstract available.
• Emerging treatments in acute myeloid leukaemia.

  Kell J. Kell J. Expert Opin Emerg Drugs. 2004 May;9(1):55-71. doi: 10.1517/eoed.9.1.55.32955. Expert Opin Emerg Drugs. 2004. PMID: 15155136 Review.
• Treatment of acute myeloid leukemia in older patients.

  Roboz GJ. Roboz GJ. Expert Rev Anticancer Ther. 2007 Mar;7(3):285-95. doi: 10.1586/14737140.7.3.285. Expert Rev Anticancer Ther. 2007. PMID: 17338649 Review.